Taysha Gene Therapies (TSHA) Short Interest Ratio & Short Volume $1.61 -0.03 (-1.83%) Closing price 04:00 PM EasternExtended Trading$1.63 +0.02 (+1.49%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Taysha Gene Therapies Short Interest DataTaysha Gene Therapies (TSHA) has a short interest of 24.08 million shares. This marks a 0.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 2.13 million shares to cover all short positions.Current Short Interest24,080,000 sharesPrevious Short Interest23,950,000 sharesChange Vs. Previous Month+0.54%Dollar Volume Sold Short$36.12 millionShort Interest Ratio5.7 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares204,940,000 sharesPercentage of Shares Shorted11.75%Today's Trading Volume1,637,593 sharesAverage Trading Volume2,133,070 sharesToday's Volume Vs. Average77% Short Selling Taysha Gene Therapies? Sign up to receive the latest short interest report for Taysha Gene Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTSHA Short Interest Over TimeTSHA Days to Cover Over TimeTSHA Percentage of Float Shorted Over Time Taysha Gene Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202524,080,000 shares $36.12 million +0.5%N/A5.7 $1.50 1/15/202523,950,000 shares $39.04 million -7.5%N/A5.4 $1.63 12/31/202425,880,000 shares $44.77 million +18.3%N/A6 $1.73 12/15/202421,880,000 shares $45.29 million +39.6%N/A5.1 $2.07 11/30/202415,670,000 shares $50.77 million -0.5%N/A3.8 $3.24 11/15/202415,750,000 shares $32.45 million -10.7%N/A4.4 $2.06 10/31/202417,640,000 shares $29.81 million -14.8%N/A8.1 $1.69 10/15/202420,700,000 shares $40.37 million +0.3%N/A13.9 $1.95 9/30/202420,640,000 shares $41.49 million +4.1%N/A13.7 $2.01 9/15/202419,830,000 shares $45.41 million -8.5%N/A9.5 $2.29 Get the Latest News and Ratings for TSHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taysha Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. 8/31/202421,660,000 shares $48.52 million +4.2%N/A9.5 $2.24 8/15/202420,780,000 shares $47.59 million -10.5%N/A8.3 $2.29 7/31/202423,210,000 shares $51.29 million +11.5%N/A8.9 $2.21 7/15/202420,810,000 shares $50.78 million +54.7%N/A7.9 $2.44 6/30/202413,450,000 shares $30.13 million -8.6%N/A4.9 $2.24 6/15/202414,720,000 shares $58.44 million -8.7%N/A6.3 $3.97 5/31/202416,120,000 shares $55.29 million -5.4%N/A6.7 $3.43 5/15/202417,040,000 shares $52.99 million +0.8%N/A6.4 $3.11 4/30/202416,910,000 shares $41.09 million +5.2%N/A6.1 $2.43 4/15/202416,070,000 shares $42.75 million -5.4%N/A5.9 $2.66 3/31/202416,990,000 shares $48.76 million +7.5%N/A6.1 $2.87 3/15/202415,810,000 shares $36.36 million +13.9%N/A6 $2.30 2/29/202413,880,000 shares $43.86 million -14.9%N/A6.3 $3.16 2/15/202416,300,000 shares $25.92 million -2.9%N/A8.3 $1.59 1/31/202416,780,000 shares $25.51 million -4.1%N/A8 $1.52 1/15/202417,490,000 shares $27.98 million -0.2%N/A7.8 $1.60 12/31/202317,530,000 shares $31.03 million +2.3%N/A7.8 $1.77 12/15/202317,130,000 shares $27.92 million +6.0%N/A8.2 $1.63 11/30/202316,160,000 shares $28.44 million +15.8%N/A7.6 $1.76 11/15/202313,950,000 shares $23.44 million +42.9%N/A5.6 $1.68 10/31/20239,760,000 shares $22.84 million -2.6%N/A1.8 $2.34 10/15/202310,020,000 shares $22.65 million -6.1%N/A1.9 $2.26 9/30/202310,670,000 shares $33.72 million +7.5%N/A2.1 $3.16 9/15/20239,930,000 shares $32.67 million +34.9%N/A2.1 $3.29 8/31/20237,360,000 shares $23.55 million +902.0%N/A1.6 $3.20 8/15/2023734,500 shares $1.60 million -33.2%3.9%0.2 $2.18 7/31/20231,100,000 shares $740,520.00 -1.8%3.0%4.4 $0.67 7/15/20231,120,000 shares $773,920.00 -12.5%3.1%4.3 $0.69 6/30/20231,280,000 shares $846,080.00 -10.5%3.5%4 $0.66 6/15/20231,430,000 shares $1.09 million +16.3%3.8%3.7 $0.77Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 5/31/20231,230,000 shares $859,647.00 +3.4%3.4%3.2 $0.70 5/15/20231,190,000 shares $824,789.00 -31.2%3.2%3 $0.69 4/30/20231,730,000 shares $1.34 million +6.1%4.7%4.1 $0.78 4/15/20231,630,000 shares $1.42 million -15.5%4.5%2.9 $0.87 3/31/20231,930,000 shares $1.54 million -18.2%5.4%3.5 $0.80 3/15/20232,360,000 shares $2.07 million -11.6%6.5%4.4 $0.88 2/28/20232,670,000 shares $2.70 million +19.7%7.3%4.7 $1.01 2/15/20232,230,000 shares $2.41 million +2.3%6.1%3.7 $1.08 1/31/20232,180,000 shares $3.58 million +26.7%6.0%2.7 $1.64 1/15/20231,720,000 shares $3.96 million +25.6%4.7%0.7 $2.30 12/30/20221,370,000 shares $3.10 million +48.0%3.8%0.5 $2.26 12/15/2022925,700 shares $2.13 million +12.3%2.5%0.4 $2.30 11/30/2022824,500 shares $1.82 million -38.5%3.8%0.3 $2.21 11/15/20221,340,000 shares $2.95 million -19.8%6.3%0.6 $2.20 10/31/20221,670,000 shares $2.87 million +73.8%11.3%0.8 $1.72 10/15/2022960,700 shares $1.53 million +8.0%4.1%0.6 $1.59 9/30/2022889,600 shares $1.72 million -5.2%3.8%8.5 $1.93 9/15/2022938,700 shares $2.92 million +5.2%4.0%6.2 $3.11 8/31/2022892,600 shares $2.82 million +3.5%3.8%5.3 $3.16 8/15/2022862,300 shares $3.74 million -7.2%3.7%4 $4.34 7/31/2022929,100 shares $3.78 million -10.7%4.1%3.8 $4.07 7/15/20221,040,000 shares $4.43 million -13.3%4.5%3.9 $4.26 6/30/20221,200,000 shares $4.46 million -26.4%5.2%3.8 $3.72 6/15/20221,630,000 shares $4.91 million -3.6%7.1%4.9 $3.01 5/31/20221,690,000 shares $4.31 million -4.5%7.7%6 $2.55 5/15/20221,770,000 shares $6.09 million +18.0%8.1%6.5 $3.44 4/30/20221,500,000 shares $5.49 million +19.1%7.2%5.4 $3.66 4/15/20221,260,000 shares $6.98 million -64.6%6.1%4.5 $5.54 3/31/20223,560,000 shares $23.21 million +4.1%17.1%15.3 $6.52 3/15/20223,420,000 shares $18.30 million +0.6%16.4%15.9 $5.35 2/28/20223,400,000 shares $21.66 million -6.6%16.4%15.3 $6.37 2/15/20223,640,000 shares $28.50 million +10.0%17.5%17 $7.83 1/31/20223,310,000 shares $26.31 million +9.2%15.9%16.2 $7.95 1/15/20223,030,000 shares $28.88 million +0.7%13.9%15.6 $9.53 12/31/20213,010,000 shares $35.07 million +18.0%14.3%16.8 $11.65 12/15/20212,550,000 shares $36.31 million -1.5%12.1%14.9 $14.24 11/30/20212,590,000 shares $33.62 million +1.2%12.3%17.7 $12.98 11/15/20212,560,000 shares $37.12 million +6.7%12.2%18.4 $14.50 10/29/20212,400,000 shares $37.54 million -4.4%11.0%19.7 $15.64 10/15/20212,510,000 shares $44.88 million -11.3%11.6%27 $17.88 9/30/20212,830,000 shares $52.69 million +3.7%13.0%28.3 $18.62 9/15/20212,730,000 shares $57.00 million No Change12.6%17.6 $20.88 8/31/20212,730,000 shares $54.27 million -0.4%12.7%16.6 $19.88 8/13/20212,740,000 shares $47.62 million -0.7%12.6%14.3 $17.38 7/30/20212,760,000 shares $47.72 million +10.8%12.8%14.1 $17.29 7/15/20212,490,000 shares $48.88 million +31.1%11.6%12.9 $19.63 6/30/20211,900,000 shares $40.28 million +37.7%9.8%9.9 $21.20 6/15/20211,380,000 shares $35.85 million -11.5%6.9%9.7 $25.98 5/28/20211,560,000 shares $35.10 million +9.9%7.8%12.7 $22.50 5/14/20211,420,000 shares $29.71 million +5.2%7.1%14.7 $20.92Grab This Altcoin Before Trump's Crypto Announcement (Ad)Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now. Click here to check it out now 4/30/20211,350,000 shares $33.75 million +2.3%6.8%16.6 $25.00 4/15/20211,320,000 shares $33.75 million -7.7%6.7%16.4 $25.57 3/31/20211,430,000 shares $29.32 million +7.5%7.2%16.5 $20.50 3/15/20211,330,000 shares $35.98 million +2.3%6.7%12.6 $27.05 2/26/20211,300,000 shares $34.93 million No Change6.6%11.1 $26.87 2/12/20211,300,000 shares $39.55 million +13.0%6.9%11 $30.42 1/29/20211,150,000 shares $33.27 million -8.7%14.9%9.3 $28.93 1/15/20211,260,000 shares $36.16 million No Change16.3%9.4 $28.70 TSHA Short Interest - Frequently Asked Questions What is Taysha Gene Therapies' current short interest? Short interest is the volume of Taysha Gene Therapies shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 24,080,000 shares of TSHA short. Learn More on Taysha Gene Therapies' current short interest. What is a good short interest ratio for Taysha Gene Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TSHA shares currently have a short interest ratio of 6.0. Learn More on Taysha Gene Therapies's short interest ratio. Which institutional investors are shorting Taysha Gene Therapies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Taysha Gene Therapies: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Taysha Gene Therapies' short interest increasing or decreasing? Taysha Gene Therapies saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 24,080,000 shares, an increase of 0.5% from the previous total of 23,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Taysha Gene Therapies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Taysha Gene Therapies: Galapagos NV (2.65%), Dyne Therapeutics, Inc. (9.39%), Immunocore Holdings plc (15.08%), Kiniksa Pharmaceuticals, Ltd. (2.67%), Structure Therapeutics Inc. (14.49%), Nurix Therapeutics, Inc. (14.43%), Arcutis Biotherapeutics, Inc. (16.16%), Ardelyx, Inc. (11.24%), Indivior PLC (1.23%), Arvinas, Inc. (15.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Taysha Gene Therapies stock? Short selling TSHA is an investing strategy that aims to generate trading profit from Taysha Gene Therapies as its price is falling. TSHA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Taysha Gene Therapies? A short squeeze for Taysha Gene Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TSHA, which in turn drives the price of the stock up even further. How often is Taysha Gene Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TSHA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies GLPG Short Squeeze DYN Short Squeeze IMCR Short Squeeze KNSA Short Squeeze GPCR Short Squeeze NRIX Short Squeeze ARQT Short Squeeze ARDX Short Squeeze INDV Short Squeeze ARVN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TSHA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSHA Stock Alerts